Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Impact of Oxygen Tension on Human Meniscus Tissue Engineering
Targeted therapy of ALL with gene-modified central memory T cells
General Clinical Research Center
Alteration in Membrane Clearances in Children on Dialysis
Renal Mechanism of Renal Hypophosphatemic X Linked Rickets
Recently added grants:
A structure-based approach to accelerated recombinase engineering
Novel carbohydrate binding functions of the CR3 I-domain modulate gonococcal-cervical cell interactions
Molecular mechanism of antigen editing by Class-I MHC Chaperones
Genetic mechanisms of snail/schistosome compatibility
DNA damage signaling to immune checkpoints
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67189-3-0-1
Application #
7574874
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Howard University
$308,392
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gordeuk, Victor /
$263,550
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant
